Journal of pediatric gastroenterology and nutritionHumansChildMaleHepatitis CChronic
Glecaprevir/pibrentasvir in patients aged 3-17 years with chronic hepatitis C: Real-life data from the POLAC project.
Anna Dobrzeniecka, Ewa Talarek, Małgorzata Aniszewska, Marta Troszczyńska, Magdalena Marczyńska, Maria Pokorska-Śpiewak
Published: 202610.1002/jpn3.70241
Abstract
OBJECTIVES: In this noncommercial, nonrandomized, open-label therapeutic program POLAC project, we aimed to analyze the efficacy and safety of the pangenotypic regimen glecaprevir/pibrentasvir (GLE/PIB) in children aged 3-17 years with chronic hepati…
Preview only. Read the full abstract at the source